PUB041 HGF, VEGFA and ANGPT2 Predict Clinical Benefit from Bevacizumab and Chemotherapy in Patients with Advanced NSCLC (SAKK19/09)

作者: Sacha Rothschild , Oliver Gautschi , Nathalie Schuster , Qiyu Li , Spasenija Savic

DOI: 10.1016/J.JTHO.2016.11.2011

关键词:

摘要:

参考文章(0)